Use and misuse of psychoactive medicines: a descriptive cross-sectional study in a densely populated region of Portugal

References

• Administração Central dos Sistemas de Saúde. (2012). Bilhete de identidade dos indicadores utilizados na contratualização dos ACES, USF e UCSP. Ministério Da Saúde.
   Google Scholar
• American Geriatrics Society Beers Criteria® Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 71(7), 2052–2081. https://doi.org/10.1111/jgs.18372
   PubMed Web of Science ®Google Scholar
• Araújo, A. C., Casal, R. J., Goulão, J., & Martins, A. P. (2022). Protocol for a scoping review on misuse of psychoactive medicines and its consequences. BMJ Open, 12(10), e060519. https://doi.org/10.1136/bmjopen-2021-060519
   Web of Science ®Google Scholar
• Araújo, A. C., Casal, R. J., Goulão, J., & Martins, A. P. (2023). Misuse of psychoactive medicines and its consequences in the European Union – A scoping review. Journal of Substance Use, 00(00), 1–12. https://doi.org/10.1080/14659891.2023.2213325
   Google Scholar
• Barrett, S. P., & Meisner, J., & Stewart S. H. (2008). What constitutes prescription drug misuse? Problems and pitfalls of current conceptualizations. Current Drug Abuse Reviews, 1(3), 255–262. https://doi.org/10.2174/1874473710801030255
   PubMedGoogle Scholar
• Bedene, A., Lijfering, W. M., Niesters, M., van Velzen, M., Rosendaal, F. R., Bouvy, M. L., Dahan, A., & Van Dorp, E. L. A. (2019). Opioid prescription patterns and risk factors associated with opioid use in the Netherlands. In JAMA network open (Vol. 2, Issue 8). American Medical Association.
   Google Scholar
• Bedson, J., Chen, Y., Hayward, R. A., Ashworth, J., Walters, K., Dunn, K. M., & Jordan, K. P. (2016). Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: An observational database study. Pain, 157(7), 1525–1531. https://doi.org/10.1097/j.pain.0000000000000557
   PubMed Web of Science ®Google Scholar
• Biernikiewicz, M., Taieb, V., & Toumi, M. (2019). Characteristics of doctor-shoppers: A systematic literature review. Journal of Market Access & Health Policy, 7(1), 1595953. https://doi.org/10.1080/20016689.2019.1595953
   PubMedGoogle Scholar
• Boyd, A., Van de Velde, S., Pivette, M., ten Have, M., Florescu, S., O’Neill, S., Caldas-de-Almeida, J. M., Vilagut, G., Haro, J. M., Alonso, J., & Kovess-Masféty, V. (2015). Gender differences in psychotropic use across Europe: Results from a large cross-sectional, population-based study. European Psychiatry, 30(6), 778–788. https://doi.org/10.1016/j.eurpsy.2015.05.001
   PubMed Web of Science ®Google Scholar
• Bramness, J. G., & Person, O. (2014). A bibliometric analysis of European versus USA research in the field of addiction. Research on alcohol, narcotics, prescription drug abuse, tobacco and steroids 2001-2011. European Addiction Research, 20(1), 16–22. https://doi.org/10.1159/000348260
   PubMed Web of Science ®Google Scholar
• Campbell, C. I., Weisner, C., LeResche, L., Ray, G. T., Saunders, K., Sullivan, M. D., Banta-Green, C. J., Merrill, J. O., Silverberg, M. J., Boudreau, D., Satre, D. D., & Von Korff, M. (2010). Age and gender trends in long-term opioid analgesic use for noncancer pain. American Journal of Public Health, 100(12), 2541–2547. https://doi.org/10.2105/AJPH.2009.180646
   PubMed Web of Science ®Google Scholar
• Carmona Araújo, A., Fernandes, E., Franco Ruivo, I., do Céu Machado, M., Faria Vaz, A., & Furtado, C. (2023). Prevalência da Dispensa de Medicamentos em Ambulatório na População Idosa em Portugal: Um Estudo Transversal. Acta Médica Portuguesa, 36(12), 792–801. https://doi.org/10.20344/amp.19254
   PubMedGoogle Scholar
• Carrasco-Garrido, P., Gallardo-Pino, C., Jiménez-Trujillo, I., Hernández-Barrera, V., García-Gómez-Heras, S., Lima Florencio, L., & Palacios-Ceña, D. (2022). Nationwide population-based study about patterns of prescription opioid use and misuse among young adults in Spain. International Journal of Public Health, 67(August), 1–10. https://doi.org/10.3389/ijph.2022.1604755
   Google Scholar
• Cartagena, F. J., Porter, L., McManus, S., Strang, J., Hickman, M., Reed, K., & Smith, N. (2017). Prescribing patterns in dependence forming medicines. http://phrc.lshtm.ac.uk/
   Google Scholar
• Casati, A., Sedefov, R., & Pfeiffer-Gerschel, T. (2012). Misuse of medicines in the European union: A systematic review of the literature. European Addiction Research, 18(5), 228–245. https://doi.org/10.1159/000337028
   PubMed Web of Science ®Google Scholar
• Chenaf, C., Kaboré, J. L., Delorme, J., Pereira, B., Mulliez, A., Zenut, M., Delage, N., Ardid, D., Eschalier, A., & Authier, N. (2019). Prescription opioid analgesic use in France: Trends and impact on morbidity–mortality. European Journal of Pain, 23(1), 124–134. https://doi.org/10.1002/ejp.1291
   PubMed Web of Science ®Google Scholar
• Chiappini, S., Vickers-Smith, R., Guirguis, A., Corkery, J. M., Martinotti, G., & Schifano, F. (2022). A focus on abuse/misuse and withdrawal issues with selective serotonin reuptake inhibitors (SSRIs): Analysis of both the European EMA and the US FAERS pharmacovigilance databases. Pharmaceuticals, 15(5), 1–17. https://doi.org/10.3390/ph15050565
   Web of Science ®Google Scholar
• Chou, R., Turner, J. A., Devine, E. B., Hansen, R. N., Sullivan, S. D., Blazina, I., Dana, T., Bougatsos, C., & Deyo, R. A. (2015). The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a national institutes of health pathways to prevention workshop. Annals of Internal Medicine, 162(4), 276–286. https://doi.org/10.7326/M14-2559
   PubMed Web of Science ®Google Scholar
• Conselho Nacional de Saúde. (2019). Sem mais tempo a perder – Saúde mental em Portugal: um desafio para a próxima década. CNS, 1–130. https://fronteirasxxi.pt/wp-content/uploads/2020/02/“Sem-mais-tempo-a-perder”-CNS-2019.pdf
   Google Scholar
• Conselho Nacional de Ética para as Ciências da Vida. (2023). Parecer 123/CNECV/2023 sobre o uso off-label de medicamentos – Implicações éticas.
   Google Scholar
• Coordenação Nacional da Estratégia do Medicamento e dos Produtos de Saúde. (2017). Sobreutilização das Benzodiazepinas e dos Z-Hipnóticos na Ansiedade e na Insónia. Ministério Da Saúde. https://www.ordemfarmaceuticos.pt
   Google Scholar
• Delaš Aždajić, M., Likić, R., Aždajić, S., Šitum, M., Lovrić, I., & Štimac Grbić, D. (2019). Outpatient benzodiazepine utilization in Croatia: Drug use or misuse. International Journal of Clinical Pharmacy, 41(6), 1526–1535. https://doi.org/10.1007/s11096-019-00915-2
   PubMed Web of Science ®Google Scholar
• Direção Geral da Saúde. (2015). Tratamento sintomático da ansiedade e insónia com benzodiazepinas e fármacos análogos. Normas de Orientação Clínica, 55/2011, 1–10.
   Google Scholar
• Driot, D., Jouanjus, E., Oustric, S., Dupouy, J., & Lapeyre-Mestre, M. (2019). Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France. British Journal of Clinical Pharmacology, 85(6), 1260–1269. https://doi.org/10.1111/bcp.13892
   PubMed Web of Science ®Google Scholar
• EMCDDA. (2023). Spotlight on … Non-medical use of benzodiazepines. 2023. https://www.emcdda.europa.eu/spotlights/non-medical-use-benzodiazepines_en
   Google Scholar
• European Medicines Agency. (2017). Good pharmacovigilance practices – Annex 1 definitions (Rev.4). Good Pharmacovigilance Practices. https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/good-pharmacovigilance-practices#final-gvp-annex-i—definitions-section
   Google Scholar
• European Medicines Agency. (2023). Guideline on clinical investigation of medicinal products in the treatment of depression. https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-clinical-investigation-medicinal-products-treatment-depression-revision-3_en.pdf
   Google Scholar
• Faria Vaz, A., Magalhães, A. S., Lourenço, A., Costa, J., Guerreiro, M., & Ribeiro, N. (2017a). Estratégias para a descontinuação de benzodiazepinas. Boletim Terapêutico – ARS LVT, Anexo I, 1–9.
   Google Scholar
• Faria Vaz, A., Magalhães, A. S., Lourenço, A., Costa, J., Guerreiro, M., & Ribeiro, N. (2017b). Utilização de Benzodiazepinas: Um grave problema de saúde pública. Boletim Terapêutico – ARS LVT, 1, 1–6.
   Google Scholar
• FDA. (2016, August 31). FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use | FDA. FDA News Release. https://www.fda.gov/news-events/press-announcements/fda-requires-strong-warnings-opioid-analgesics-prescription-opioid-cough-products-and-benzodiazepine
   Google Scholar
• Fernandes, M., Neves, I., Oliveira, J., Santos, O., Aguiar, P., Atalaia, P., Matos, F., Freitas, C., Alvim, A., & Maria, V. (2022). Discontinuation of chronic benzodiazepine use in primary care: A nonrandomized intervention. Family Practice, 39(3), 563. https://doi.org/10.1093/fampra/cmac037
   PubMed Web of Science ®Google Scholar
• Frauger, E., Amaslidou, D., Spadari, M., Allaria-Lapierre V., Braunstein D., Sciortino V., Thirion X., Djezzar S., & Micallef, J. (2016). Patterns of methylphenidate use and assessment of its abuse among the general population and individuals with drug dependence. European Addiction Research, 22(3), 119–126. https://doi.org/10.1159/000439273
   PubMed Web of Science ®Google Scholar
• Frauger, E., Pauly, V., Pradel, V., Rouby, F., Arditti, J., Thirion, X., Lapeyre Mestre, M., & Micallef, J. (2011). Evidence of clonazepam abuse liability: Results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network. Fundamental & Clinical Pharmacology, 25(5), 633–641. https://doi.org/10.1111/j.1472-8206.2010.00882.x
   PubMed Web of Science ®Google Scholar
• Friedman, J., & Shover, C. L. (2023). Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010–2021. Addiction, 118(12), 2477–2485. http://doi.org/10.1111/add.v118.12
   PubMed Web of Science ®Google Scholar
• Ghent University – Faculty of Pharmaceutical Sciences. (2023). Ghent Older People’s Prescriptions community Pharmacy Screening (GheOP3S)-tool – Version 2. 390. https://www.ugent.be/fw/nl/onderzoek/bioanalyse/farmzorg/tools/gheop3s-tool-versie-2/gheop3s-tool-update_eng/view
   Google Scholar
• Gomes, S., Broeiro-Gonçalves, P., Meireles, C., Caldeira, D., Costa, J., Guerreiro, M. P., Ribeiro, N., & Afonso, R. (2023). Prescrição de Benzodiazepinas e outros Sedativos na Administração Regional de Saúde de Lisboa e Vale do Tejo de 2013 a 2020: Um Estudo Retrospetivo. Acta Médica Portuguesa, 36(4), 264–274. https://doi.org/10.20344/amp.18680
   PubMedGoogle Scholar
• Hägg, S., Jönsson, A. K., & Ahlner, J. (2020). Current evidence on abuse and misuse of gabapentinoids. Drug Safety, 43(12), 1235–1254. https://doi.org/10.1007/s40264-020-00985-6
   PubMed Web of Science ®Google Scholar
• Haukka, J., Kriikku, P., Mariottini, C., Partonen, T., & Ojanperä O. I. (2018). Non-medical use of psychoactive prescription drugs is associated with fatal poisoning. Addiction, 113(3), 464–472. https://doi.org/10.1111/add.14014
   PubMed Web of Science ®Google Scholar
• Hedenmalm, K., Slattery, J., Skibicka-Stepien, I., Kurz, X., & Morales, D. (2019). Prescribing patterns of tramadol in adults in IMS® primary care databases in France and Germany between 1 January 2006 and 30 June 2016. European Journal of Clinical Pharmacology, 75(5), 707–716. https://doi.org/10.1007/s00228-018-02622-9
   PubMed Web of Science ®Google Scholar
• Hider-Mlynarz, K., Cavalié, P., & Maison, P. (2018). Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe. British Journal of Clinical Pharmacology, 84(6), 1324–1334. https://doi.org/10.1111/bcp.13564
   PubMed Web of Science ®Google Scholar
• Hockenhull, J., Black, J. C., Haynes, C. M., Rockhill, K., Dargan, P. I., Dart, R. C., & Wood, D. M. (2021). Nonmedical use of benzodiazepines and Z-drugs in the UK. British Journal of Clinical Pharmacology, 87(4), 1676–1683. https://doi.org/10.1111/bcp.14397
   PubMed Web of Science ®Google Scholar
• INFARMED. (2017). Benzodiazepinas e Análogos. Infarmed. http://www.infarmed.pt/documents/15786/2219894/Utlilização+de+Benzodiazepinas+e+análogos/adb100fa-4a77-4eb7-9e67-99229e13154f
   Google Scholar
• INFARMED. (2020). Psicofármacos na última década em Portugal. INFARMED Notícias, 71, 26–29. https://www.infarmed.pt/web/infarmed/institucional/documentacao_e_informacao/publicacoes/institucionais/infarmed_noticias/infarmed-noticias-arquivo
   Google Scholar
• Kalkman, G. A., Kramers, C., van Dongen, R. T., van den Brink, W., & Schellekens, A. (2019). Trends in use and misuse of opioids in the Netherlands: A retrospective, multi-source database study. The Lancet Public Health, 2667(19), E498-E505. https://doi.org/10.1016/S2468-2667(19)30128-8
   Google Scholar
• Keto, J., Heiskanen, T., Hamunen, K., Kalliomäki, M. L., & Linna, M. (2022). Opioid trends in Finland: A register-based nationwide follow-up study. Scientific Reports, 12(1), 1–9. doi:10.1038/s41598-022-10788-7
   PubMed Web of Science ®Google Scholar
• Khan, N. F., Bykov, K., Glynn, R. J., Barnett, M. L., & Gagne J. J. (2021). Coprescription of opioids with other medications and risk of opioid overdose. Clinical Pharmacology & Therapeutics, 110(4), 1011–1017. https://doi.org/10.1002/cpt.2314
   PubMed Web of Science ®Google Scholar
• Kostnapfel, T., Jandl, M., Hocevar Grom, A., Korosec, A., & Kastelic, A. (2022). Prescription opioid use and opioid-related mortality monitoring in Slovenia. Heroin Addiction and Related Clinical Problems, 24(4), 33–39.
   Web of Science ®Google Scholar
• Kurko, T. A., Saastamoinen, L. K., Tähkäpää, S., Tuulio-Henriksson, A., Taiminen, T., Tiihonen, J., Airaksinen, M. S., & Hietala, J. (2015). Long-term use of benzodiazepines: Definitions, prevalence and usage patterns – A systematic review of register-based studies. European Psychiatry, 30(8), 1037–1047. https://doi.org/10.1016/j.eurpsy.2015.09.003
   PubMed Web of Science ®Google Scholar
• Kurko, T., Saastamoinen, L. K., Tuulio-Henriksson, A., Taiminen, T., Tiihonen, J., Airaksinen, M., & Hietala, J. (2018). Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014. Pharmacoepidemiology and Drug Safety, 27(6), 674–682. https://doi.org/10.1002/pds.4551
   PubMed Web of Science ®Google Scholar
• Langan, S. M., Schmidt, S. A., Wing, K., Ehrenstein, V., Nicholls, S. G., Filion, K. B., Klungel, O., Petersen, I., Sorensen, H. T., Dixon, W. G., Guttmann, A., Harron, K., Hemkens, L. G., Moher, D., Schneeweiss, S., Smeeth, L., Sturkenboom, M., von Elm, E., Wang, S. V., & Benchimol, E. I. (2018). The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ, 363, k3532. https://doi.org/10.1136/bmj.k3532
   PubMedGoogle Scholar
• Lombardi, N., Bettiol, A., Crescioli, G., Ravaldi, C., Bonaiuti, R., Venegoni, M., Vighi, G. D., Mugelli, A., Mannaioni, G., Vannacci, A., Aiezza, M. L., Bettoni, D., Blandizzi, C., Borsi, V., Capuano, A., Cecchi, E., Convertino, I., Lungo, M., Del Mauro, C., … Di Vighi, G. V. (2020). Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: A nationwide multicentre study in emergency departments. Internal and Emergency Medicine, 15(7), 1291–1302. https://doi.org/10.1007/s11739-020-02339-7
   PubMed Web of Science ®Google Scholar
• Luijendijk, H. J., Tiemeier, H., Hofman, A., Heeringa, J., & Stricker, B. H. C. (2008). Determinants of chronic benzodiazepine use in the elderly: A longitudinal study. British Journal of Clinical Pharmacology, 65(4), 593–599. https://doi.org/10.1111/j.1365-2125.2007.03060.x
   PubMed Web of Science ®Google Scholar
• Lunghi, C., Antonazzo, I. C., Burato, S., Raschi, E., Zoffoli, V., Forcesi, E., Sangiorgi, E., Menchetti, M., Roberge, P., & Poluzzi, E. (2020). Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study. Neuropsychiatric Disease and Treatment, 16, 1157–1170. https://doi.org/10.2147/NDT.S241780
   PubMed Web of Science ®Google Scholar
• Madeira, L., Queiroz, G., & Henriques, R. (2023). Prepandemic psychotropic drug status in Portugal: A nationwide pharmacoepidemiological profile. Scientific Reports, 13(1), 1–13. doi:10.1038/s41598-023-33765-0
   PubMed Web of Science ®Google Scholar
• Marschall, U., L’Hoest, H., Radbruch, L., & Häuser, W. (2016). Long-term opioid therapy for chronic non-cancer pain in Germany. European Journal of Pain, 20(5), 767–776. https://doi.org/10.1002/ejp.802
   PubMed Web of Science ®Google Scholar
• Mellbye, A., Karlstad, Ø., Skurtveit, S., Borchgrevink, P. C., & Fredheim, O. M. (2016). The duration and course of opioid therapy in patients with chronic non-malignant pain. Acta Anaesthesiologica Scandinavica, 60(1), 128–137. https://doi.org/10.1111/aas.12594
   PubMed Web of Science ®Google Scholar
• Micallef, J., Frauger, E., Palmaro, A., Boucherie, Q., & Lapeyre Mestre, M. (2015). Example of an investigation of an “emergent” phenomenon in addiction vigilance: The case of methylphenidate. Therapies, 70(2), 197–202. https://doi.org/10.2515/therapie/2015013
   Web of Science ®Google Scholar
• Motta-Ochoa, R., Bertrand, K., Arruda, N., Jutras-Aswad, D., & Roy, É. (2017). “I love having benzos after my coke shot”: The use of psychotropic medication among cocaine users in downtown Montreal. International Journal of Drug Policy, 49, 15–23. https://doi.org/10.1016/j.drugpo.2017.07.012
   PubMed Web of Science ®Google Scholar
• Muller, A. E., Clausen, T., Sjøgren, P., Odsbu, I., & Skurtveit, S. (2019). Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017. Scandinavian Journal of Pain, 19(2), 345–353. https://doi.org/10.1515/sjpain-2018-0307
   PubMed Web of Science ®Google Scholar
• Nielsen, S., Gisev, N., Bruno, R., Hall, W., Cohen, M., Larance, B., Campbell, G., Shanahan, M., Blyth, F., Lintzeris, N., Pearson, S., Mattick, R., & Degenhardt, L. (2017). Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment. Pharmacoepidemiology and Drug Safety, 26(5), 587–591. https://doi.org/10.1002/pds.4168
   PubMed Web of Science ®Google Scholar
• Nordmann, S., Pradel, V., Lapeyre-Mestre, M., Frauger, E., Pauly, V., Thirion, X., Mallaret, M., Jouanjus, E., & Micallef, J. (2013). Doctor shopping reveals geographical variations in opioid abuse. Pain Physician, 16(1), 89–100.
   PubMed Web of Science ®Google Scholar
• Novak, S. P., Håkansson, A., Martinez-Raga, J., Reimer, J., Krotki, K., & Varughese, S. (2016). Nonmedical use of prescription drugs in the European Union. BMC Psychiatry, 16(1), 1–12. doi:10.1186/s12888-016-0909-3
   PubMed Web of Science ®Google Scholar
• OECD. (2020). Health at a Glance: Europe 2020. OECD Publishing.
   Google Scholar
• OECD. (2023). Pharmaceutical market | OECD Health Statistics | OECD iLibrary. https://www.oecd.org/els/health-systems/health-data.htm
   Google Scholar
• OECD European Observatory on Health Systems and Policies. (2023). Country health profile 2023, State of Health in the EU – Portugal.
   Google Scholar
• Oliveira, J., Neves, I., Fernandes, M., Santos, O., & Maria, V. (2019). Prescribing and facilitating withdrawal from benzodiazepines in primary health care. Revista Portuguesa de Clínica Geral, 35(4), 305–312. https://doi.org/10.32385/rpmgf.v35i4.12239
   Google Scholar
• O’Mahony, D., Cherubini, A., Guiteras, A. R., Denkinger, M., Beuscart, J. B., Onder, G., Gudmundsson, A., Cruz-Jentoft, A. J., Knol, W., Bahat, G., van der Velde, N., Petrovic, M., & Curtin, D. (2023). STOPP/START criteria for potentially inappropriate prescribing in older people: Version 3. European Geriatric Medicine, 14(4), 625–632. https://doi.org/10.1007/s41999-023-00777-y
   PubMedGoogle Scholar
• OsMed. (n.d.). National report on medicines use in Italy 2017. 2017. https://www.aifa.gov.it/documents/20142/241052/OsMed_2017_eng.pdf
   Google Scholar
• Pierce, M., van Amsterdam, J., Kalkman, G. A., Schellekens, A., & van den Brink, W. (2021). Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018. European Psychiatry, 64(1), 1–18. https://doi.org/10.1192/j.eurpsy.2021.2219
   PubMed Web of Science ®Google Scholar
• Ponté, C., Lepelley, M., Boucherie, Q., Mallaret, M., Lapeyre Mestre, M., Pradel, V., & Micallef, J. (2018). Doctor shopping of opioid analgesics relative to benzodiazepines: A pharmacoepidemiological study among 11.7 million inhabitants in the French countries. Drug and Alcohol Dependence, 187, 88–94. https://doi.org/10.1016/j.drugalcdep.2018.01.036
   PubMed Web of Science ®Google Scholar
• Pradel, V., Delga, C., Rouby, F., Micallef, J., & Lapeyre-Mestre, M. (2010). Assessment of abuse potential of benzodiazepines from a prescription database using ‘doctor shopping’ as an indicator. CNS Drugs, 24(7), 611–620. https://doi.org/10.2165/11531570-000000000-00000
   PubMed Web of Science ®Google Scholar
• Pradel, V., Frauger, E., Thirion, X., Ronfle, E., Lapierre, V., Masut, A., Coudert, C., Blin, O., & Micallef, J. (2009). Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiology and Drug Safety, 18(1), 36–43. https://doi.org/10.1002/pds.1681
   PubMed Web of Science ®Google Scholar
• Pradel, V., Thirion, X., Ronfle, E., Masut, A., Micallef, J., & Bégaud, B. (2004). Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: Development of a new method for prescription database. Pharmacoepidemiology and Drug Safety, 13(7), 473–481. https://doi.org/10.1002/pds.892
   PubMed Web of Science ®Google Scholar
• Prazeres, F. (2023). Letter to the editor on the identification of potentially inappropriate medications among elderly patients in ambulatory care in Portugal. Acta Médica Portuguesa, 36(12), 850–851. https://doi.org/10.20344/amp.20389
   PubMed Web of Science ®Google Scholar
• Public Health England. (2019). Dependence and withdrawal associated with some prescribed medicines – An evidence review. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/829777/PHE_PMR_report.pdf
   Google Scholar
• Regueras, E., & López Guzmán, J. (2021). Cómo es el uso de medicamentos opioides en España? Análisis de los datos de la encuesta EDADES 2017. Multidisciplinary Pain Journal, 1, 141–148. https://doi.org/10.20986/MPJ.2021.1005/2021
   Google Scholar
• Rodrigues, D. A., Herdeiro, M. T., Thurmann, P. A., Figueiras, A., Coutinho, P., & Roque, F. (2020). Operacionalização para Portugal da Lista EU(7)-PIM para Identificação de Medicamentos Potencialmente Inapropriados nos Idosos [Operationalisation for Portugal of the EU(7)-PIM list for identification of potentially inappropriate medicines in older adults]. Acta Médica Portuguesa, 33(13), 194–200. www.actamedicaportuguesa.com
   Google Scholar
• Rossow, I., & Bramness, J. G. (2015). The total sale of prescription drugs with an abuse potential predicts the number of excessive users: A national prescription database study Health behavior, health promotion and society. BMC Public Health, 15(1), 1–9. doi:10.1186/s12889-015-1615-7
   PubMedGoogle Scholar
• Rouby, F., Pradel, V., Frauger, E., Pauly, V., Natali, F., Reggio, P., Thirion, X., & Micallef, J. (2012). Assessment of abuse of tianeptine from a reimbursement database using ‘doctor-shopping’ as an indicator. Fundamental & Clinical Pharmacology, 26(2), 286–294. https://doi.org/10.1111/j.1472-8206.2010.00906.x
   PubMed Web of Science ®Google Scholar
• Roussin, A., Palmaro, A., & Lapeyre-Mestre, M. (2016). Weak opioid analgesics abuse and addiction. In Neuropathology of drug addictions and substance misuse (pp. 375–391). Elsevier. https://doi.org/10.1016/B978-0-12-800634-4.00036-6
   Google Scholar
• Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis A. (2018). Abuse of prescription drugs in the context of novel psychoactive substances (NPS): A systematic review. Brain Sciences, 8(4), 73, https://doi.org/10.3390/brainsci8040073
   Web of Science ®Google Scholar
• Schjerning, O., Pottegård, A., Damkier, P., Rosenzweig, M., & Nielsen, J. (2016). Use of pregabalin – A nationwide pharmacoepidemiological drug utilization study with focus on abuse potential. Pharmacopsychiatry, 49(4), 155–161. https://doi.org/10.1055/s-0042-101868
   PubMed Web of Science ®Google Scholar
• Schonmann, Y., Goren, O., Bareket, R., Comaneshter, D., Cohen, A. D., & Vinker, S. (2018). Chronic hypnotic use at 10 years – Does the brand matter? European Journal of Clinical Pharmacology, 74(12), 1623–1631. https://doi.org/10.1007/s00228-018-2531-4
   PubMed Web of Science ®Google Scholar
• Simonsen, K. W., Kriikku, P., Thelander, G., Edvardsen, H. M. E., Thordardottir, S., Andersen, C. U., Jönsson, A. K., Frost, J., Christoffersen, D. J., Delaveris, G. J. M., & Ojanperä, I. (2020). Fatal poisoning in drug addicts in the Nordic countries in 2017. Forensic Science International, 313, 110343. https://doi.org/10.1016/j.forsciint.2020.110343
   PubMed Web of Science ®Google Scholar
• Smith, S. M., Dart, R. C., Katz, N. P., Paillard. F., Adams, E. H., Comer, S. D., Degroot, A., Edwards, R. R., Haddox, D. J., Jaffe, J. H., Jones, C. M., Kleber, H. D., Kopecky, E. A., Markman, J. D., Montoya, I. D., O'Brien C., Roland C. L., Stanton, M., … Dworkin, R. H. (2017). Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain, 154(11), 2287–2296. https://doi.org/10.1016/j.pain.2013.05.053
   Google Scholar
• Soeiro, T., Micallef, J., & Pradel, V. (2023). Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators : A nation-wide, repeated cross-sectional study. Addiction, 118(10), 1984–1993. https://doi.org/10.1111/add.16261
   Google Scholar
• Torrance, N., Mansoor, R., Wang, H., Gilbert, S., Macfarlane, G. J., Serpell, M., Baldacchino, A., Hales, T. G., Donnan, P., Wyper, G., Smith, B. H., & Colvin, L. (2018). Association of opioid prescribing practices with chronic pain and benzodiazepine co-prescription: A primary care data linkage study. British Journal of Anaesthesia, 120(6), 1345–1355. https://doi.org/10.1016/j.bja.2018.02.022
   PubMed Web of Science ®Google Scholar
• Transnational Institute. (2015). The UN drug control conventions. https://www.tni.org/en/publication/the-un-drug-control-conventions
   Google Scholar
• United Nations Office on Drug and Crime. (2017a). World Drug Report 2017 Booklet 2 – GLOBAL OVERVIEW OF DRUG DEMAND AND SUPPLY. Retrieved April 30, 2023, from www.unodc.org/wdr2017
   Google Scholar
• United Nations Office on Drugs and Crime. (2017b). Non-medical use of benzodiazepines: a growing threat to public health? Global SMART Update, 18, 1-12, www.unodc.org/unodc/en/
   Google Scholar
• van Amsterdam, J., & van den Brink, W. (2015). The misuse of prescription opioids: A threat for Europe? Current Drug Abuse Reviews, 8(1), 3–14. https://doi.org/10.2174/187447370801150611184218
   PubMedGoogle Scholar
• Wei, Y.-J. J., Zhu, Y., Liu, W., Bussing, R., & Winterstein, A. G. (2018). Prevalence of and factors associated with long-term concurrent use of stimulants and opioids among adults with attention-deficit/hyperactivity disorder. JAMA Network Open, 1(4), e181152. https://doi.org/10.1001/jamanetworkopen.2018.1152
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics and Methodology. (2022a). WHOCC – Structure and principles. Retrieved May 26, 2023, from https://www.whocc.no/atc/structure_and_principles/
   Google Scholar
• WHO Collaboration Centre for Drug Statistics Methodology. (2022b). Guidelines for ATC classification and DDD assignment. https://www.whocc.no/atc_ddd_index_and_guidelines/guidelines/
   Google Scholar
• Wood, D. M., & Dargan, P. I. (2021). Regional, national and international datasets: How they improve our understanding of the acute harms associated with prescription medicine misuse. British Journal of Clinical Pharmacology, 87(4), 1654–1659. https://doi.org/10.1111/bcp.14592
   PubMed Web of Science ®Google Scholar
• World Health Organization. (n.d.). International classification of primary care (2nd ed.). ICPC-2. Retrieved May 12, 2023, from https://www.who.int/standards/classifications/other-classifications/international-classification-of-primary-care.
   Google Scholar
• Worley, J., & Thomas, S. P. (2014). Women who doctor shop for prescription drugs. Western Journal of Nursing Research, 36(4), 456–474. https://doi.org/10.1177/0193945913509692
   PubMed Web of Science ®Google Scholar
• Zin, C. S., Chen, L. C., & Knaggs, R. D. (2014). Changes in trends and pattern of strong opioid prescribing in primary care. European Journal of Pain, 18(9), 1343–1351. https://doi.org/10.1002/j.1532-2149.2014.496.x
   PubMed Web of Science ®Google Scholar